Investing Ideas
/
French Pharmaceuticals & Biotech Nano Cap Stocks

French Pharmaceuticals & Biotech Nano Cap Stocks

Results

1 new

Stocks with a market cap under US$50M.

4 companies

GenSight Biologics

Market Cap: €19.0m

A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.

New

SIGHT

€0.08

-4.5%

-33.6%

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

ALPHE

€2.00

2.6%

-53.6%

Poxel

Market Cap: €10.8m

A clinical-stage biopharmaceutical company, develops novel treatments for metabolic pathophysiology, type 2 diabetes, and liver diseases.

POXEL

€0.20

-0.5%

-66.4%

Aton

Market Cap: €8.4m

Operates as a bioscience company in France.

ALTAO

€0.01

-3.8%

21.4%